A Venture Studio
for High-Impact Biotechnology
Who We Are
Omnium Ventures is the venture studio division of Omnium Global.
We invest capital, leadership, and execution capacity into emerging biotechnology companies to turn strong ideas into scalable, fundable, high-impact ventures.
Our approach is hands-on and outcomes-driven: we join companies as fractional executives, build strategy alongside founders, and leverage our extensive global network to accelerate development and unlock meaningful opportunities.
Our Venture Studio Model
A True Partner in Execution
Omnium Ventures is not a passive investor.
We co-build companies — side by side with founders — to maximize their probability of success.
Where We Invest
We focus on ventures where execution, scientific rigor, & commercialization strategy must come together:
• Drug delivery platforms
• Vaccines and infectious disease technologies
• AI/ML-powered biotech tools
• Advanced manufacturing systems
• Low-cost biologics and LMIC access models
• Ophthalmology, immunology, oncology, rare diseases
• Enabling technologies (CMC, formulation, polymer chemistry, etc.)
What We Bring To Founders
Operational Acceleration
We help teams hit critical milestones (preclinical, IND-enabling, CMC readiness, first-in-human studies).
​
Fundraising Strategy & Investor Access
We prepare companies for investment, structure deals, develop valuation stories, and facilitate high-quality introductions.
Company-Building Infrastructure
We help founders establish:
• Governance and board structure
• IP strategy
• Product development plans
• CMC and regulatory pathways
• Partnering and out-licensing strategies
We Invest Capital
Seed and early-stage investment into teams and technologies aligned with global health, therapeutic innovation, AI-enabled biopharma tools, and advanced biomanufacturing.
We Invest Time and Leadership
Our team works directly inside companies as:
• Fractional CEOs
• Fractional COOs
• Fractional CSOs / CMC Leaders
• Commercial Strategy Leads
• Fundraising Leads
• Partnership Builders
We do the work — writing strategies, building pitch decks, leading CMC, running diligence, negotiating deals, and building operational foundations.
We Leverage Our Global Network
We connect founders with:
• Investors (VCs, corporates, family offices, foundations)
• CDMOs and CROs
• Scientific and technical experts
• Global health organizations
• Big Pharma and regional pharma partners
• LMIC manufacturing networks
This network is one of Omnium’s strongest differentiators, opening doors that most early-stage companies cannot reach alone.
Our Vision
To back breakthrough ideas
with the capital, talent, and execution required to bring them to life.